R Boellaard
Overview
Explore the profile of R Boellaard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
1258
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eertink J, Zwezerijnen G, Heymans M, Pieplenbosch S, Wiegers S, Duhrsen U, et al.
Blood
. 2023 Mar;
141(25):3055-3064.
PMID: 37001036
The objective of this study is to externally validate the clinical positron emission tomography (PET) model developed in the HOVON-84 trial and to compare the model performance of our clinical...
2.
Eertink J, Arens A, Huijbregts J, Celik F, de Keizer B, Stroobants S, et al.
Eur J Nucl Med Mol Imaging
. 2021 Sep;
49(3):943-952.
PMID: 34476551
Purpose: MYC gene rearrangements in diffuse large B-cell lymphoma (DLBCL) patients are associated with poor prognosis. Our aim was to compare patterns of 2[F]fluoro-2-deoxy-D-glucose positron emission tomography computed tomography (PET/CT)...
3.
Eertink J, Burggraaff C, Heymans M, Duhrsen U, Huttmann A, Schmitz C, et al.
Blood Adv
. 2021 May;
5(9):2375-2384.
PMID: 33944897
Interim 18F-fluorodeoxyglucose positron emission tomography (Interim-18F-FDG-PET, hereafter I-PET) has the potential to guide treatment of patients with diffuse large B-cell lymphoma (DLBCL) if the prognostic value is known. The aim...
4.
Verwer E, Golla S, Kaalep A, Lubberink M, van Velden F, Bettinardi V, et al.
Eur J Nucl Med Mol Imaging
. 2021 Jan;
48(9):2856-2870.
PMID: 33517517
Purpose: In order to achieve comparability of image quality, harmonisation of PET system performance is imperative. In this study, prototype harmonisation criteria for PET brain studies were developed. Methods: Twelve...
5.
Wolters E, van de Beek M, Ossenkoppele R, Golla S, Verfaillie S, Coomans E, et al.
Neuroimage Clin
. 2021 Jan;
28:102504.
PMID: 33395993
Purpose: Alpha-synuclein often co-occurs with Alzheimer's disease (AD) pathology in Dementia with Lewy Bodies (DLB). From a dynamic [F]flortaucipir PET scan we derived measures of both tau binding and relative...
6.
Bodar Y, Jansen B, van der Voorn J, Zwezerijnen G, Meijer D, Nieuwenhuijzen J, et al.
World J Urol
. 2020 Oct;
39(7):2439-2446.
PMID: 33079250
Purpose: In primary prostate cancer (PCa) patients, accurate staging and histologic grading are crucial to guide treatment decisions. F-DCFPyL (PSMA)-PET/CT has been successfully introduced for (re)staging PCa, showing high accuracy...
7.
Jansen B, Bodar Y, Zwezerijnen G, Meijer D, van der Voorn J, Nieuwenhuijzen J, et al.
Eur J Nucl Med Mol Imaging
. 2020 Aug;
48(2):509-520.
PMID: 32789599
Purpose: The detection of lymph-node metastases (N1) with conventional imaging such as magnetic resonance imaging (MRI) and computed tomography (CT) is inadequate for primarily diagnosed prostate cancer (PCa). Prostate-specific membrane...
8.
van Helden E, Elias S, Gerritse S, van Es S, Boon E, Huisman M, et al.
Eur J Nucl Med Mol Imaging
. 2020 Jun;
47(10):2481.
PMID: 32535653
Missing Electronic Supplementary Materials.
9.
Wielaard J, Habraken J, Brinks P, Lavalaye J, Boellaard R
EJNMMI Phys
. 2020 Apr;
7(1):20.
PMID: 32297142
Optimization of injected gallium-68 (Ga) activity for Ga-prostate-specific membrane antigen positron emission tomography/computed tomography (Ga-PSMA PET/CT) studies is relevant for image quality, radiation protection, and from an economic point of...
10.
Cysouw M, Jansen B, Yaqub M, Voortman J, Vis A, van Moorselaar R, et al.
Mol Imaging Biol
. 2020 Jan;
22(1):18.
PMID: 31907848
The article was updated to correct the following errors due to an error in production.